US Patent Issued to UNITED ARAB EMIRATES UNIVERSITY on Jan. 13 for "Method of liver cancer treatment with safranal-based formulations" (Emirati Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,425, issued on Jan. 13, was assigned to UNITED ARAB EMIRATES UNIVERSITY (Al-Ain, United Arab Emirates).

"Method of liver cancer treatment with safranal-based formulations" was invented by Amr Amin (Al Ain, United Arab Emirates) and Ala'a Al Hrout (Al Ain, United Arab Emirates).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating, suppressing, or reducing the severity of a liver cancer in a subject are described herein. The disclosed methods involve administering a therapeutically effective amount of a composition including safranal or its pharmaceutically acceptable pro-drug, and a pharmaceutically acceptable carrier to the subject. The...